19-35125412-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_139284.3(LGI4):c.1395G>A(p.Gln465=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.361 in 1,608,378 control chromosomes in the GnomAD database, including 107,999 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.35 ( 9415 hom., cov: 32)
Exomes 𝑓: 0.36 ( 98584 hom. )
Consequence
LGI4
NM_139284.3 synonymous
NM_139284.3 synonymous
Scores
1
4
8
Clinical Significance
Conservation
PhyloP100: 2.30
Genes affected
LGI4 (HGNC:18712): (leucine rich repeat LGI family member 4) Involved in regulation of myelination. Predicted to be located in extracellular region. Predicted to be active in extracellular space. Implicated in arthrogryposis multiplex congenita-1 and childhood absence epilepsy. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=2.2032857E-4).
BP6
Variant 19-35125412-C-T is Benign according to our data. Variant chr19-35125412-C-T is described in ClinVar as [Benign]. Clinvar id is 1272294.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.3 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.526 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LGI4 | NM_139284.3 | c.1395G>A | p.Gln465= | synonymous_variant | 9/9 | ENST00000310123.8 | NP_644813.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LGI4 | ENST00000310123.8 | c.1395G>A | p.Gln465= | synonymous_variant | 9/9 | 1 | NM_139284.3 | ENSP00000312273 | P1 |
Frequencies
GnomAD3 genomes AF: 0.348 AC: 52724AN: 151596Hom.: 9415 Cov.: 32
GnomAD3 genomes
AF:
AC:
52724
AN:
151596
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.364 AC: 87702AN: 241074Hom.: 16671 AF XY: 0.378 AC XY: 49333AN XY: 130680
GnomAD3 exomes
AF:
AC:
87702
AN:
241074
Hom.:
AF XY:
AC XY:
49333
AN XY:
130680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.363 AC: 528644AN: 1456664Hom.: 98584 Cov.: 43 AF XY: 0.370 AC XY: 268012AN XY: 724114
GnomAD4 exome
AF:
AC:
528644
AN:
1456664
Hom.:
Cov.:
43
AF XY:
AC XY:
268012
AN XY:
724114
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.348 AC: 52753AN: 151714Hom.: 9415 Cov.: 32 AF XY: 0.351 AC XY: 26001AN XY: 74090
GnomAD4 genome
AF:
AC:
52753
AN:
151714
Hom.:
Cov.:
32
AF XY:
AC XY:
26001
AN XY:
74090
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1303
ALSPAC
AF:
AC:
1374
ESP6500AA
AF:
AC:
1450
ESP6500EA
AF:
AC:
3054
ExAC
AF:
AC:
43559
Asia WGS
AF:
AC:
1345
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
P;P;P
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
Vest4
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at